Skip to content
Catalyst

knowcompoundsNAD(+)

Specimen compound organic compound, cationPlate I

NAD(+)

A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage.

Continue

It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (nadh). (Dorland, 27th ed)”

Nested hairline contours trace the electron density of one computed shape of NAD(+), teal at the edge warming to amber over the atoms.

432 readings, by contour and atom

fig. 1NAD(+) · electron density · PubChem CID 5893, computed 3D conformer
Formula
C21H28N7O14P2+
Molar mass
664.438 g/mol
PubChem CID
5893
InChIKey
BAWFJGJZGIEFAR-NNYOXOHSSA-O

↑ raised

01 · the evidence, ordered

What the evidence says

Fig. 2 NAD(+) CHEBI:15846 1 endpoint its finding
×1.60
Labels
CompoundInspector

NAD(+)

5 reference statements, not drawn · 2 compounds on the outer ring, not drawn

Keys

← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it

02 · findings

What NAD(+) moved, and by how much

  • Dose studied: as its paper gave it.
  • Evidence strength: computed from the study. How it is computed
  1. Left ventricular ejection fractionMoved: raisesEvidence: Very limitedPaper: PMID 429616392026
    Who
    Patients with ST-segment elevation myocardial infarction undergoing primary PCI, all receiving standard medical therapy; LVEF at 30 days
    Dose studied
    intravenous NAD+ 10 mg/day for 7 days

    At 30 days, the NAD⁺ group demonstrated a modest but significant improvement in LVEF compared with the placebo group (56.32 ± 8.04% vs. 53.37 ± 8.12%, p = 0.048).”

    Quoted verbatim from Effect of Intravenous Nicotinamide Adenine Dinucleotide on Left Ventricular Function After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Trial.RCT · 7 daysPermalink

No dose is advised.

  • Dose studied: as its paper gave it.
  • Evidence strength: computed from the study. How it is computed

03 · identity

Structure

fig. 3NAD(+) · 2D structure · ChEBI’s SMILES
fig. 4NAD(+) · 3D conformer · PubChem CID 5893, computed
Charge
+1
SMILES
NC(=O)c1ccc[n+]([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c1
Description on record
The oxidised form of nicotinamide adenine dinucleotide found in all living cells. In metabolism, NAD+ is involved in redox reactions, carrying electrons from one reaction to another.

04 · documented · reference

Interactions

Documented interactions
None reported

Pairs that share biology

What the reference databases state

Reference statements
501 ProteinSLC25A17inferred, one hop from NAD(+)
Reactions · Rhea
625reactions
5Reference statements

What the reference databases state

Evidence key

Statements

5 statements

NAD(+) is transported by each

625Reactions

05 · on the label · 128 products

Labelled products

Source: NIH DSLD · Ingredient: NAD(+) · 128 products · Declared amount per serving: 0.025–1,000 mg

63 labels state an amount65 do not

  • 7T PharmaGenicin Vita-Q5 mgper 1 tabletDSLD:263274
  • Alive By NatureLSG NAD+250 mgper 2 mLDSLD:230821
  • Alive By NatureLSG NAD+250 mgper 2 mLDSLD:230822
  • Alive By NaturePure NAD+125 mgper 1 scoopDSLD:230854
  • Alive By NatureSublingual Pure NAD+125 mgper 1 tabletDSLD:230852
  • Alive By ScienceLIPO NAD+ Complete150 mgper 1 vegetarian capsuleDSLD:264769
  • Alive By ScienceNAD+ Micromist25 mgper 2 spraysDSLD:266191
  • Allergy Research GroupMitochondrial CofactorsBeta-Nicotinamide Adenine Dinucleotide · reduced B-Nicotinamide Adenine Dinucleotide5 mgper 3 capsulesDSLD:304257
  • Applied NutritionLibido-Maxamount not statedper 1 liquid soft-gelDSLD:323143
  • Axis Pharmaceutics Inc.VitaXyme5 mgper 1 tabletDSLD:263320
  • Axis Pharmaceutics Inc.Vitazyme Tablets5 mgper 1 tabletDSLD:263329
  • Axis Pharmaceutics Inc.Vitazyme Tablets5 mgper 1 tabletDSLD:263341
Show the remaining 116Show the first 12

Label record: NIH Office of Dietary Supplements · CC0

06 · the record

Sources

360

papers screened for NAD(+)

admitted
1
read and discarded
140
not read yet
219

The screening record, every paper and why

Sources cited

1 paper · 1 finding

Show every paper citedHide the papers cited

Other names · 8

β-NAD · Diphosphopyridine nucleotide · DPN · NAD · NAD+ · Nadide · Nicotinamide adenine dinucleotide

systematic · adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate}